Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin may be important for skin growth and immune function.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Continuing education programs significantly increased rural nurse practitioners' knowledge about PCOS.

A woman with Sheehan syndrome improved with hormone treatment.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.